Based on survival analysis, COX regression analysis, and ROC curve analysis, we concluded that IGF2BP3 was closely involved in the bad prognosis in HCC patients and was an individual risk element. The gene discussed is IGF2BP3; the disease is hepatocellular carcinoma.